nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.313	1	CpDpCtD
Trisalicylate-choline—PTGS2—epilepsy syndrome	0.143	1	CbGaD
Trisalicylate-choline—Magnesium salicylate—Carbamazepine—epilepsy syndrome	0.119	0.342	CrCrCtD
Trisalicylate-choline—Magnesium salicylate—Oxcarbazepine—epilepsy syndrome	0.11	0.315	CrCrCtD
Trisalicylate-choline—Salsalate—Carbamazepine—epilepsy syndrome	0.0621	0.179	CrCrCtD
Trisalicylate-choline—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0573	0.165	CrCrCtD
Trisalicylate-choline—PTGS1—Diazepam—epilepsy syndrome	0.0389	0.559	CbGbCtD
Trisalicylate-choline—PTGS1—Valproic Acid—epilepsy syndrome	0.0306	0.441	CbGbCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—epilepsy syndrome	0.000241	0.365	CrCbGaD
Trisalicylate-choline—Magnesium salicylate—ALB—epilepsy syndrome	0.000215	0.325	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—epilepsy syndrome	0.000205	0.31	CrCbGaD
Trisalicylate-choline—Somnolence—Phenytoin—epilepsy syndrome	8.45e-05	0.00074	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Clonazepam—epilepsy syndrome	8.42e-05	0.000737	CcSEcCtD
Trisalicylate-choline—Somnolence—Oxcarbazepine—epilepsy syndrome	8.4e-05	0.000736	CcSEcCtD
Trisalicylate-choline—Nausea—Clobazam—epilepsy syndrome	8.4e-05	0.000736	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Pregabalin—epilepsy syndrome	8.38e-05	0.000734	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Phenytoin—epilepsy syndrome	8.36e-05	0.000732	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Valproic Acid—epilepsy syndrome	8.36e-05	0.000732	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Felbamate—epilepsy syndrome	8.36e-05	0.000732	CcSEcCtD
Trisalicylate-choline—Anorexia—Lamotrigine—epilepsy syndrome	8.36e-05	0.000732	CcSEcCtD
Trisalicylate-choline—Dizziness—Acetazolamide—epilepsy syndrome	8.34e-05	0.00073	CcSEcCtD
Trisalicylate-choline—Urticaria—Diazepam—epilepsy syndrome	8.32e-05	0.000729	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Oxcarbazepine—epilepsy syndrome	8.32e-05	0.000729	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Clonazepam—epilepsy syndrome	8.32e-05	0.000728	CcSEcCtD
Trisalicylate-choline—Pruritus—Propofol—epilepsy syndrome	8.28e-05	0.000725	CcSEcCtD
Trisalicylate-choline—Tinnitus—Pregabalin—epilepsy syndrome	8.27e-05	0.000724	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Phenytoin—epilepsy syndrome	8.26e-05	0.000723	CcSEcCtD
Trisalicylate-choline—Flushing—Pregabalin—epilepsy syndrome	8.23e-05	0.00072	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Oxcarbazepine—epilepsy syndrome	8.22e-05	0.000719	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Topiramate—epilepsy syndrome	8.19e-05	0.000717	CcSEcCtD
Trisalicylate-choline—Constipation—Clonazepam—epilepsy syndrome	8.18e-05	0.000716	CcSEcCtD
Trisalicylate-choline—Pain—Clonazepam—epilepsy syndrome	8.18e-05	0.000716	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Zonisamide—epilepsy syndrome	8.18e-05	0.000716	CcSEcCtD
Trisalicylate-choline—Hepatitis—Gabapentin—epilepsy syndrome	8.13e-05	0.000712	CcSEcCtD
Trisalicylate-choline—Constipation—Phenytoin—epilepsy syndrome	8.13e-05	0.000711	CcSEcCtD
Trisalicylate-choline—Pruritus—Midazolam—epilepsy syndrome	8.11e-05	0.00071	CcSEcCtD
Trisalicylate-choline—Hallucination—Gabapentin—epilepsy syndrome	8.09e-05	0.000708	CcSEcCtD
Trisalicylate-choline—Pain—Oxcarbazepine—epilepsy syndrome	8.08e-05	0.000708	CcSEcCtD
Trisalicylate-choline—Constipation—Oxcarbazepine—epilepsy syndrome	8.08e-05	0.000708	CcSEcCtD
Trisalicylate-choline—Somnolence—Carbamazepine—epilepsy syndrome	8.06e-05	0.000706	CcSEcCtD
Trisalicylate-choline—Urticaria—Felbamate—epilepsy syndrome	8.06e-05	0.000705	CcSEcCtD
Trisalicylate-choline—Vomiting—Acetazolamide—epilepsy syndrome	8.02e-05	0.000702	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Propofol—epilepsy syndrome	8.01e-05	0.000701	CcSEcCtD
Trisalicylate-choline—Pruritus—Levetiracetam—epilepsy syndrome	8e-05	0.000701	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Carbamazepine—epilepsy syndrome	7.98e-05	0.000699	CcSEcCtD
Trisalicylate-choline—Headache—Acetazolamide—epilepsy syndrome	7.9e-05	0.000691	CcSEcCtD
Trisalicylate-choline—Urticaria—Zonisamide—epilepsy syndrome	7.89e-05	0.00069	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Carbamazepine—epilepsy syndrome	7.89e-05	0.00069	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Clonazepam—epilepsy syndrome	7.88e-05	0.00069	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Phenytoin—epilepsy syndrome	7.83e-05	0.000686	CcSEcCtD
Trisalicylate-choline—Somnolence—Lamotrigine—epilepsy syndrome	7.79e-05	0.000682	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	7.79e-05	0.000682	CcSEcCtD
Trisalicylate-choline—Weight increased—Topiramate—epilepsy syndrome	7.78e-05	0.000681	CcSEcCtD
Trisalicylate-choline—Pain—Carbamazepine—epilepsy syndrome	7.76e-05	0.000679	CcSEcCtD
Trisalicylate-choline—Constipation—Carbamazepine—epilepsy syndrome	7.76e-05	0.000679	CcSEcCtD
Trisalicylate-choline—Dizziness—Propofol—epilepsy syndrome	7.74e-05	0.000678	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Levetiracetam—epilepsy syndrome	7.74e-05	0.000678	CcSEcCtD
Trisalicylate-choline—Pruritus—Fosphenytoin—epilepsy syndrome	7.72e-05	0.000676	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Lamotrigine—epilepsy syndrome	7.72e-05	0.000676	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Gabapentin—epilepsy syndrome	7.69e-05	0.000673	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Lamotrigine—epilepsy syndrome	7.62e-05	0.000667	CcSEcCtD
Trisalicylate-choline—Urticaria—Clonazepam—epilepsy syndrome	7.6e-05	0.000665	CcSEcCtD
Trisalicylate-choline—Tinnitus—Gabapentin—epilepsy syndrome	7.58e-05	0.000664	CcSEcCtD
Trisalicylate-choline—Dizziness—Midazolam—epilepsy syndrome	7.58e-05	0.000663	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Pregabalin—epilepsy syndrome	7.56e-05	0.000662	CcSEcCtD
Trisalicylate-choline—Urticaria—Phenytoin—epilepsy syndrome	7.55e-05	0.000661	CcSEcCtD
Trisalicylate-choline—Pruritus—Vigabatrin—epilepsy syndrome	7.53e-05	0.000659	CcSEcCtD
Trisalicylate-choline—Urticaria—Oxcarbazepine—epilepsy syndrome	7.51e-05	0.000657	CcSEcCtD
Trisalicylate-choline—Pain—Lamotrigine—epilepsy syndrome	7.5e-05	0.000656	CcSEcCtD
Trisalicylate-choline—Constipation—Lamotrigine—epilepsy syndrome	7.5e-05	0.000656	CcSEcCtD
Trisalicylate-choline—Nausea—Acetazolamide—epilepsy syndrome	7.49e-05	0.000656	CcSEcCtD
Trisalicylate-choline—Dizziness—Levetiracetam—epilepsy syndrome	7.48e-05	0.000655	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Carbamazepine—epilepsy syndrome	7.47e-05	0.000654	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Fosphenytoin—epilepsy syndrome	7.47e-05	0.000654	CcSEcCtD
Trisalicylate-choline—Vomiting—Propofol—epilepsy syndrome	7.44e-05	0.000652	CcSEcCtD
Trisalicylate-choline—Pruritus—Diazepam—epilepsy syndrome	7.41e-05	0.000649	CcSEcCtD
Trisalicylate-choline—Rash—Propofol—epilepsy syndrome	7.38e-05	0.000646	CcSEcCtD
Trisalicylate-choline—Dermatitis—Propofol—epilepsy syndrome	7.38e-05	0.000646	CcSEcCtD
Trisalicylate-choline—Headache—Propofol—epilepsy syndrome	7.34e-05	0.000642	CcSEcCtD
Trisalicylate-choline—Vomiting—Midazolam—epilepsy syndrome	7.28e-05	0.000638	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vigabatrin—epilepsy syndrome	7.28e-05	0.000638	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Lamotrigine—epilepsy syndrome	7.22e-05	0.000633	CcSEcCtD
Trisalicylate-choline—Rash—Midazolam—epilepsy syndrome	7.22e-05	0.000632	CcSEcCtD
Trisalicylate-choline—Dizziness—Fosphenytoin—epilepsy syndrome	7.22e-05	0.000632	CcSEcCtD
Trisalicylate-choline—Dermatitis—Midazolam—epilepsy syndrome	7.22e-05	0.000632	CcSEcCtD
Trisalicylate-choline—Urticaria—Carbamazepine—epilepsy syndrome	7.21e-05	0.000631	CcSEcCtD
Trisalicylate-choline—Vomiting—Levetiracetam—epilepsy syndrome	7.19e-05	0.00063	CcSEcCtD
Trisalicylate-choline—Epistaxis—Topiramate—epilepsy syndrome	7.19e-05	0.000629	CcSEcCtD
Trisalicylate-choline—Headache—Midazolam—epilepsy syndrome	7.18e-05	0.000628	CcSEcCtD
Trisalicylate-choline—Pruritus—Felbamate—epilepsy syndrome	7.17e-05	0.000628	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Diazepam—epilepsy syndrome	7.17e-05	0.000628	CcSEcCtD
Trisalicylate-choline—Rash—Levetiracetam—epilepsy syndrome	7.13e-05	0.000625	CcSEcCtD
Trisalicylate-choline—Dermatitis—Levetiracetam—epilepsy syndrome	7.13e-05	0.000624	CcSEcCtD
Trisalicylate-choline—Headache—Levetiracetam—epilepsy syndrome	7.09e-05	0.000621	CcSEcCtD
Trisalicylate-choline—Erythema—Gabapentin—epilepsy syndrome	7.08e-05	0.00062	CcSEcCtD
Trisalicylate-choline—Dizziness—Vigabatrin—epilepsy syndrome	7.04e-05	0.000616	CcSEcCtD
Trisalicylate-choline—Confusional state—Valproic Acid—epilepsy syndrome	7.02e-05	0.000615	CcSEcCtD
Trisalicylate-choline—Pruritus—Zonisamide—epilepsy syndrome	7.02e-05	0.000615	CcSEcCtD
Trisalicylate-choline—Oedema—Valproic Acid—epilepsy syndrome	6.97e-05	0.00061	CcSEcCtD
Trisalicylate-choline—Urticaria—Lamotrigine—epilepsy syndrome	6.96e-05	0.00061	CcSEcCtD
Trisalicylate-choline—Nausea—Propofol—epilepsy syndrome	6.96e-05	0.000609	CcSEcCtD
Trisalicylate-choline—Vomiting—Fosphenytoin—epilepsy syndrome	6.94e-05	0.000608	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Felbamate—epilepsy syndrome	6.94e-05	0.000607	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Gabapentin—epilepsy syndrome	6.93e-05	0.000607	CcSEcCtD
Trisalicylate-choline—Dizziness—Diazepam—epilepsy syndrome	6.93e-05	0.000607	CcSEcCtD
Trisalicylate-choline—Rash—Fosphenytoin—epilepsy syndrome	6.88e-05	0.000603	CcSEcCtD
Trisalicylate-choline—Dermatitis—Fosphenytoin—epilepsy syndrome	6.88e-05	0.000602	CcSEcCtD
Trisalicylate-choline—Headache—Fosphenytoin—epilepsy syndrome	6.84e-05	0.000599	CcSEcCtD
Trisalicylate-choline—Hepatitis—Topiramate—epilepsy syndrome	6.84e-05	0.000599	CcSEcCtD
Trisalicylate-choline—Nausea—Midazolam—epilepsy syndrome	6.8e-05	0.000596	CcSEcCtD
Trisalicylate-choline—Hallucination—Topiramate—epilepsy syndrome	6.8e-05	0.000596	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Zonisamide—epilepsy syndrome	6.79e-05	0.000595	CcSEcCtD
Trisalicylate-choline—Pruritus—Clonazepam—epilepsy syndrome	6.77e-05	0.000593	CcSEcCtD
Trisalicylate-choline—Vomiting—Vigabatrin—epilepsy syndrome	6.77e-05	0.000592	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.73e-05	0.00059	CcSEcCtD
Trisalicylate-choline—Pruritus—Phenytoin—epilepsy syndrome	6.72e-05	0.000589	CcSEcCtD
Trisalicylate-choline—Nausea—Levetiracetam—epilepsy syndrome	6.72e-05	0.000588	CcSEcCtD
Trisalicylate-choline—Rash—Vigabatrin—epilepsy syndrome	6.71e-05	0.000588	CcSEcCtD
Trisalicylate-choline—Dizziness—Felbamate—epilepsy syndrome	6.71e-05	0.000587	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vigabatrin—epilepsy syndrome	6.7e-05	0.000587	CcSEcCtD
Trisalicylate-choline—Pruritus—Oxcarbazepine—epilepsy syndrome	6.69e-05	0.000586	CcSEcCtD
Trisalicylate-choline—Headache—Vigabatrin—epilepsy syndrome	6.67e-05	0.000584	CcSEcCtD
Trisalicylate-choline—Vomiting—Diazepam—epilepsy syndrome	6.66e-05	0.000583	CcSEcCtD
Trisalicylate-choline—Anorexia—Valproic Acid—epilepsy syndrome	6.64e-05	0.000581	CcSEcCtD
Trisalicylate-choline—Rash—Diazepam—epilepsy syndrome	6.61e-05	0.000578	CcSEcCtD
Trisalicylate-choline—Dermatitis—Diazepam—epilepsy syndrome	6.6e-05	0.000578	CcSEcCtD
Trisalicylate-choline—Dizziness—Zonisamide—epilepsy syndrome	6.56e-05	0.000575	CcSEcCtD
Trisalicylate-choline—Headache—Diazepam—epilepsy syndrome	6.56e-05	0.000575	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Clonazepam—epilepsy syndrome	6.55e-05	0.000573	CcSEcCtD
Trisalicylate-choline—Hypotension—Valproic Acid—epilepsy syndrome	6.51e-05	0.00057	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Phenytoin—epilepsy syndrome	6.5e-05	0.000569	CcSEcCtD
Trisalicylate-choline—Nausea—Fosphenytoin—epilepsy syndrome	6.49e-05	0.000568	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.47e-05	0.000566	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Topiramate—epilepsy syndrome	6.47e-05	0.000566	CcSEcCtD
Trisalicylate-choline—Vomiting—Felbamate—epilepsy syndrome	6.45e-05	0.000565	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—AQP4—epilepsy syndrome	6.42e-05	0.00534	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Carbamazepine—epilepsy syndrome	6.42e-05	0.000562	CcSEcCtD
Trisalicylate-choline—Rash—Felbamate—epilepsy syndrome	6.39e-05	0.00056	CcSEcCtD
Trisalicylate-choline—Dermatitis—Felbamate—epilepsy syndrome	6.39e-05	0.000559	CcSEcCtD
Trisalicylate-choline—Tinnitus—Topiramate—epilepsy syndrome	6.38e-05	0.000558	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	6.37e-05	0.0053	CbGpPWpGaD
Trisalicylate-choline—Headache—Felbamate—epilepsy syndrome	6.35e-05	0.000556	CcSEcCtD
Trisalicylate-choline—Confusional state—Pregabalin—epilepsy syndrome	6.35e-05	0.000556	CcSEcCtD
Trisalicylate-choline—Flushing—Topiramate—epilepsy syndrome	6.35e-05	0.000556	CcSEcCtD
Trisalicylate-choline—Dizziness—Clonazepam—epilepsy syndrome	6.33e-05	0.000554	CcSEcCtD
Trisalicylate-choline—Nausea—Vigabatrin—epilepsy syndrome	6.32e-05	0.000553	CcSEcCtD
Trisalicylate-choline—Vomiting—Zonisamide—epilepsy syndrome	6.31e-05	0.000553	CcSEcCtD
Trisalicylate-choline—Oedema—Pregabalin—epilepsy syndrome	6.3e-05	0.000551	CcSEcCtD
Trisalicylate-choline—Dizziness—Phenytoin—epilepsy syndrome	6.28e-05	0.00055	CcSEcCtD
Trisalicylate-choline—Rash—Zonisamide—epilepsy syndrome	6.26e-05	0.000548	CcSEcCtD
Trisalicylate-choline—Dermatitis—Zonisamide—epilepsy syndrome	6.25e-05	0.000547	CcSEcCtD
Trisalicylate-choline—Dizziness—Oxcarbazepine—epilepsy syndrome	6.25e-05	0.000547	CcSEcCtD
Trisalicylate-choline—Nausea—Diazepam—epilepsy syndrome	6.22e-05	0.000545	CcSEcCtD
Trisalicylate-choline—Headache—Zonisamide—epilepsy syndrome	6.22e-05	0.000544	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Carbamazepine—epilepsy syndrome	6.21e-05	0.000543	CcSEcCtD
Trisalicylate-choline—Pruritus—Lamotrigine—epilepsy syndrome	6.2e-05	0.000543	CcSEcCtD
Trisalicylate-choline—Shock—Pregabalin—epilepsy syndrome	6.2e-05	0.000542	CcSEcCtD
Trisalicylate-choline—Somnolence—Valproic Acid—epilepsy syndrome	6.19e-05	0.000542	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Valproic Acid—epilepsy syndrome	6.13e-05	0.000537	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.09e-05	0.000533	CcSEcCtD
Trisalicylate-choline—Vomiting—Clonazepam—epilepsy syndrome	6.08e-05	0.000533	CcSEcCtD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—epilepsy syndrome	6.07e-05	0.00505	CbGpPWpGaD
Trisalicylate-choline—Decreased appetite—Valproic Acid—epilepsy syndrome	6.06e-05	0.00053	CcSEcCtD
Trisalicylate-choline—Vomiting—Phenytoin—epilepsy syndrome	6.04e-05	0.000529	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	6.03e-05	0.00502	CbGpPWpGaD
Trisalicylate-choline—Rash—Clonazepam—epilepsy syndrome	6.03e-05	0.000528	CcSEcCtD
Trisalicylate-choline—Dermatitis—Clonazepam—epilepsy syndrome	6.03e-05	0.000528	CcSEcCtD
Trisalicylate-choline—Nausea—Felbamate—epilepsy syndrome	6.02e-05	0.000527	CcSEcCtD
Trisalicylate-choline—Vomiting—Oxcarbazepine—epilepsy syndrome	6.01e-05	0.000526	CcSEcCtD
Trisalicylate-choline—Anorexia—Pregabalin—epilepsy syndrome	6e-05	0.000526	CcSEcCtD
Trisalicylate-choline—Dizziness—Carbamazepine—epilepsy syndrome	6e-05	0.000525	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Lamotrigine—epilepsy syndrome	6e-05	0.000525	CcSEcCtD
Trisalicylate-choline—Headache—Clonazepam—epilepsy syndrome	5.99e-05	0.000525	CcSEcCtD
Trisalicylate-choline—Rash—Phenytoin—epilepsy syndrome	5.99e-05	0.000525	CcSEcCtD
Trisalicylate-choline—Dermatitis—Phenytoin—epilepsy syndrome	5.99e-05	0.000524	CcSEcCtD
Trisalicylate-choline—Rash—Oxcarbazepine—epilepsy syndrome	5.96e-05	0.000522	CcSEcCtD
Trisalicylate-choline—Pain—Valproic Acid—epilepsy syndrome	5.96e-05	0.000522	CcSEcCtD
Trisalicylate-choline—Constipation—Valproic Acid—epilepsy syndrome	5.96e-05	0.000522	CcSEcCtD
Trisalicylate-choline—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.95e-05	0.000521	CcSEcCtD
Trisalicylate-choline—Headache—Phenytoin—epilepsy syndrome	5.95e-05	0.000521	CcSEcCtD
Trisalicylate-choline—Erythema—Topiramate—epilepsy syndrome	5.95e-05	0.000521	CcSEcCtD
Trisalicylate-choline—Headache—Oxcarbazepine—epilepsy syndrome	5.92e-05	0.000518	CcSEcCtD
Trisalicylate-choline—Nausea—Zonisamide—epilepsy syndrome	5.9e-05	0.000516	CcSEcCtD
Trisalicylate-choline—Hypotension—Pregabalin—epilepsy syndrome	5.88e-05	0.000515	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Topiramate—epilepsy syndrome	5.83e-05	0.00051	CcSEcCtD
Trisalicylate-choline—Confusional state—Gabapentin—epilepsy syndrome	5.82e-05	0.00051	CcSEcCtD
Trisalicylate-choline—Dizziness—Lamotrigine—epilepsy syndrome	5.8e-05	0.000508	CcSEcCtD
Trisalicylate-choline—Oedema—Gabapentin—epilepsy syndrome	5.78e-05	0.000506	CcSEcCtD
Trisalicylate-choline—Vomiting—Carbamazepine—epilepsy syndrome	5.77e-05	0.000505	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.74e-05	0.000503	CcSEcCtD
Trisalicylate-choline—Rash—Carbamazepine—epilepsy syndrome	5.72e-05	0.000501	CcSEcCtD
Trisalicylate-choline—Dermatitis—Carbamazepine—epilepsy syndrome	5.71e-05	0.0005	CcSEcCtD
Trisalicylate-choline—Nausea—Clonazepam—epilepsy syndrome	5.68e-05	0.000498	CcSEcCtD
Trisalicylate-choline—Headache—Carbamazepine—epilepsy syndrome	5.68e-05	0.000498	CcSEcCtD
Trisalicylate-choline—Shock—Gabapentin—epilepsy syndrome	5.68e-05	0.000497	CcSEcCtD
Trisalicylate-choline—Nausea—Phenytoin—epilepsy syndrome	5.64e-05	0.000494	CcSEcCtD
Trisalicylate-choline—Nausea—Oxcarbazepine—epilepsy syndrome	5.61e-05	0.000492	CcSEcCtD
Trisalicylate-choline—Somnolence—Pregabalin—epilepsy syndrome	5.6e-05	0.00049	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.58e-05	0.000489	CcSEcCtD
Trisalicylate-choline—Vomiting—Lamotrigine—epilepsy syndrome	5.57e-05	0.000488	CcSEcCtD
Trisalicylate-choline—Urticaria—Valproic Acid—epilepsy syndrome	5.53e-05	0.000485	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	5.53e-05	0.0046	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	5.53e-05	0.0046	CbGpPWpGaD
Trisalicylate-choline—Rash—Lamotrigine—epilepsy syndrome	5.53e-05	0.000484	CcSEcCtD
Trisalicylate-choline—Dermatitis—Lamotrigine—epilepsy syndrome	5.52e-05	0.000484	CcSEcCtD
Trisalicylate-choline—Anorexia—Gabapentin—epilepsy syndrome	5.5e-05	0.000482	CcSEcCtD
Trisalicylate-choline—Headache—Lamotrigine—epilepsy syndrome	5.49e-05	0.000481	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—PLAT—epilepsy syndrome	5.48e-05	0.00456	CbGpPWpGaD
Trisalicylate-choline—Decreased appetite—Pregabalin—epilepsy syndrome	5.47e-05	0.000479	CcSEcCtD
Trisalicylate-choline—Hypotension—Gabapentin—epilepsy syndrome	5.4e-05	0.000472	CcSEcCtD
Trisalicylate-choline—Nausea—Carbamazepine—epilepsy syndrome	5.39e-05	0.000472	CcSEcCtD
Trisalicylate-choline—Pain—Pregabalin—epilepsy syndrome	5.39e-05	0.000472	CcSEcCtD
Trisalicylate-choline—Constipation—Pregabalin—epilepsy syndrome	5.39e-05	0.000472	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CAT—epilepsy syndrome	5.35e-05	0.00445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	5.28e-05	0.00439	CbGpPWpGaD
Trisalicylate-choline—Nausea—Lamotrigine—epilepsy syndrome	5.21e-05	0.000456	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—epilepsy syndrome	5.2e-05	0.00432	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Pregabalin—epilepsy syndrome	5.19e-05	0.000454	CcSEcCtD
Trisalicylate-choline—Somnolence—Gabapentin—epilepsy syndrome	5.13e-05	0.000449	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Gabapentin—epilepsy syndrome	5.08e-05	0.000445	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Gabapentin—epilepsy syndrome	5.02e-05	0.00044	CcSEcCtD
Trisalicylate-choline—Urticaria—Pregabalin—epilepsy syndrome	5e-05	0.000438	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—epilepsy syndrome	4.95e-05	0.00412	CbGpPWpGaD
Trisalicylate-choline—Constipation—Gabapentin—epilepsy syndrome	4.94e-05	0.000432	CcSEcCtD
Trisalicylate-choline—Pain—Gabapentin—epilepsy syndrome	4.94e-05	0.000432	CcSEcCtD
Trisalicylate-choline—Pruritus—Valproic Acid—epilepsy syndrome	4.93e-05	0.000432	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL2—epilepsy syndrome	4.92e-05	0.00409	CbGpPWpGaD
Trisalicylate-choline—Confusional state—Topiramate—epilepsy syndrome	4.9e-05	0.000429	CcSEcCtD
Trisalicylate-choline—Oedema—Topiramate—epilepsy syndrome	4.86e-05	0.000425	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—GPX1—epilepsy syndrome	4.84e-05	0.00402	CbGpPWpGaD
Trisalicylate-choline—Shock—Topiramate—epilepsy syndrome	4.78e-05	0.000419	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Valproic Acid—epilepsy syndrome	4.77e-05	0.000417	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Gabapentin—epilepsy syndrome	4.76e-05	0.000417	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP2C19—epilepsy syndrome	4.75e-05	0.00395	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP11A1—epilepsy syndrome	4.72e-05	0.00393	CbGpPWpGaD
Trisalicylate-choline—Hyperhidrosis—Topiramate—epilepsy syndrome	4.7e-05	0.000411	CcSEcCtD
Trisalicylate-choline—Anorexia—Topiramate—epilepsy syndrome	4.63e-05	0.000405	CcSEcCtD
Trisalicylate-choline—Dizziness—Valproic Acid—epilepsy syndrome	4.61e-05	0.000403	CcSEcCtD
Trisalicylate-choline—Urticaria—Gabapentin—epilepsy syndrome	4.59e-05	0.000402	CcSEcCtD
Trisalicylate-choline—Hypotension—Topiramate—epilepsy syndrome	4.54e-05	0.000397	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	4.47e-05	0.00372	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—epilepsy syndrome	4.46e-05	0.00371	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Pregabalin—epilepsy syndrome	4.46e-05	0.00039	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCR2—epilepsy syndrome	4.45e-05	0.0037	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Valproic Acid—epilepsy syndrome	4.43e-05	0.000388	CcSEcCtD
Trisalicylate-choline—Rash—Valproic Acid—epilepsy syndrome	4.39e-05	0.000385	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	4.39e-05	0.00365	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	4.39e-05	0.00365	CbGpPWpGaD
Trisalicylate-choline—Dermatitis—Valproic Acid—epilepsy syndrome	4.39e-05	0.000384	CcSEcCtD
Trisalicylate-choline—Headache—Valproic Acid—epilepsy syndrome	4.36e-05	0.000382	CcSEcCtD
Trisalicylate-choline—Somnolence—Topiramate—epilepsy syndrome	4.32e-05	0.000378	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pregabalin—epilepsy syndrome	4.31e-05	0.000377	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Topiramate—epilepsy syndrome	4.28e-05	0.000374	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP2D6—epilepsy syndrome	4.26e-05	0.00354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—epilepsy syndrome	4.26e-05	0.00354	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—epilepsy syndrome	4.24e-05	0.00353	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CAT—epilepsy syndrome	4.24e-05	0.00353	CbGpPWpGaD
Trisalicylate-choline—Decreased appetite—Topiramate—epilepsy syndrome	4.22e-05	0.00037	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.19e-05	0.00349	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—HES1—epilepsy syndrome	4.18e-05	0.00348	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Pregabalin—epilepsy syndrome	4.16e-05	0.000365	CcSEcCtD
Trisalicylate-choline—Constipation—Topiramate—epilepsy syndrome	4.15e-05	0.000364	CcSEcCtD
Trisalicylate-choline—Pain—Topiramate—epilepsy syndrome	4.15e-05	0.000364	CcSEcCtD
Trisalicylate-choline—Nausea—Valproic Acid—epilepsy syndrome	4.14e-05	0.000362	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	4.1e-05	0.00341	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	4.1e-05	0.00341	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Gabapentin—epilepsy syndrome	4.09e-05	0.000358	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS1—epilepsy syndrome	4.08e-05	0.00339	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Pregabalin—epilepsy syndrome	4e-05	0.000351	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Topiramate—epilepsy syndrome	4e-05	0.000351	CcSEcCtD
Trisalicylate-choline—Rash—Pregabalin—epilepsy syndrome	3.97e-05	0.000348	CcSEcCtD
Trisalicylate-choline—Dermatitis—Pregabalin—epilepsy syndrome	3.97e-05	0.000347	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gabapentin—epilepsy syndrome	3.95e-05	0.000346	CcSEcCtD
Trisalicylate-choline—Headache—Pregabalin—epilepsy syndrome	3.95e-05	0.000345	CcSEcCtD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.93e-05	0.00327	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	3.91e-05	0.00325	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	3.86e-05	0.00321	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Topiramate—epilepsy syndrome	3.86e-05	0.000338	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	3.84e-05	0.00319	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.83e-05	0.00319	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Gabapentin—epilepsy syndrome	3.82e-05	0.000334	CcSEcCtD
Trisalicylate-choline—Nausea—Pregabalin—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.69e-05	0.00307	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Gabapentin—epilepsy syndrome	3.67e-05	0.000321	CcSEcCtD
Trisalicylate-choline—Rash—Gabapentin—epilepsy syndrome	3.64e-05	0.000319	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gabapentin—epilepsy syndrome	3.64e-05	0.000319	CcSEcCtD
Trisalicylate-choline—Headache—Gabapentin—epilepsy syndrome	3.62e-05	0.000317	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CCL2—epilepsy syndrome	3.49e-05	0.0029	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	3.48e-05	0.0029	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Topiramate—epilepsy syndrome	3.44e-05	0.000301	CcSEcCtD
Trisalicylate-choline—Nausea—Gabapentin—epilepsy syndrome	3.43e-05	0.0003	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	3.37e-05	0.0028	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.35e-05	0.00279	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.33e-05	0.00277	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Topiramate—epilepsy syndrome	3.32e-05	0.000291	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	3.32e-05	0.00276	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	3.3e-05	0.00274	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—epilepsy syndrome	3.25e-05	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA13—epilepsy syndrome	3.25e-05	0.0027	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Topiramate—epilepsy syndrome	3.21e-05	0.000281	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	3.2e-05	0.00266	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Topiramate—epilepsy syndrome	3.09e-05	0.00027	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	3.07e-05	0.00255	CbGpPWpGaD
Trisalicylate-choline—Rash—Topiramate—epilepsy syndrome	3.06e-05	0.000268	CcSEcCtD
Trisalicylate-choline—Dermatitis—Topiramate—epilepsy syndrome	3.06e-05	0.000268	CcSEcCtD
Trisalicylate-choline—Headache—Topiramate—epilepsy syndrome	3.04e-05	0.000266	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.04e-05	0.00253	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.99e-05	0.00249	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—RELA—epilepsy syndrome	2.93e-05	0.00244	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.93e-05	0.00244	CbGpPWpGaD
Trisalicylate-choline—Nausea—Topiramate—epilepsy syndrome	2.89e-05	0.000253	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	2.85e-05	0.00237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.79e-05	0.00232	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	2.77e-05	0.00231	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.66e-05	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—epilepsy syndrome	2.65e-05	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.62e-05	0.00218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	2.58e-05	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA13—epilepsy syndrome	2.58e-05	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	2.56e-05	0.00213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	2.47e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FAR1—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PDXK—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—L2HGDH—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADK—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GLUD1—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CERS1—epilepsy syndrome	2.46e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	2.43e-05	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	2.4e-05	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDXK—epilepsy syndrome	2.33e-05	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	2.33e-05	0.00193	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.26e-05	0.00188	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—EPM2A—epilepsy syndrome	2.25e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PNPO—epilepsy syndrome	2.25e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NHLRC1—epilepsy syndrome	2.25e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GAMT—epilepsy syndrome	2.25e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.25e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	2.24e-05	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	2.22e-05	0.00185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	2.19e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PNPO—epilepsy syndrome	2.14e-05	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EPM2A—epilepsy syndrome	2.14e-05	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NHLRC1—epilepsy syndrome	2.14e-05	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	2.1e-05	0.00175	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—QDPR—epilepsy syndrome	2.09e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA4—epilepsy syndrome	2.09e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—POMC—epilepsy syndrome	2.09e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.08e-05	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SV2A—epilepsy syndrome	1.99e-05	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—COX3—epilepsy syndrome	1.97e-05	0.00164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CERS1—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FAR1—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADK—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PDXK—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLUD1—epilepsy syndrome	1.96e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.92e-05	0.0016	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	1.87e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PFKL—epilepsy syndrome	1.87e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	1.87e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—KCNB1—epilepsy syndrome	1.87e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	1.87e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.82e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.81e-05	0.00151	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—EPM2A—epilepsy syndrome	1.79e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	1.79e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GAMT—epilepsy syndrome	1.79e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PNPO—epilepsy syndrome	1.79e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PFKL—epilepsy syndrome	1.77e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.71e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UPB1—epilepsy syndrome	1.71e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ATIC—epilepsy syndrome	1.71e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NEU1—epilepsy syndrome	1.71e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	1.66e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—QDPR—epilepsy syndrome	1.66e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA4—epilepsy syndrome	1.66e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	1.66e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	1.64e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STX1B—epilepsy syndrome	1.62e-05	0.00135	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GBE1—epilepsy syndrome	1.59e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	1.59e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	1.57e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—COX3—epilepsy syndrome	1.56e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.55e-05	0.00129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.53e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GBE1—epilepsy syndrome	1.5e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP1R3C—epilepsy syndrome	1.5e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CPSF4—epilepsy syndrome	1.5e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ASAH1—epilepsy syndrome	1.49e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.49e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PFKL—epilepsy syndrome	1.48e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	1.48e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—KCNB1—epilepsy syndrome	1.48e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	1.48e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	1.48e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—STXBP1—epilepsy syndrome	1.45e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.45e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.44e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NT5E—epilepsy syndrome	1.41e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALAD—epilepsy syndrome	1.41e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NEU1—epilepsy syndrome	1.36e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ATIC—epilepsy syndrome	1.36e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UPB1—epilepsy syndrome	1.36e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	1.35e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	1.35e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.35e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	1.32e-05	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	1.3e-05	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADSL—epilepsy syndrome	1.29e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.28e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GLUL—epilepsy syndrome	1.27e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.26e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.26e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.25e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	1.25e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.23e-05	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.21e-05	0.001	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.18e-05	0.000985	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.16e-05	0.000969	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.15e-05	0.000958	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.13e-05	0.000941	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.13e-05	0.000939	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.12e-05	0.000934	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.12e-05	0.000934	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.1e-05	0.000912	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.09e-05	0.000903	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.07e-05	0.000891	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.07e-05	0.000891	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.05e-05	0.000872	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.03e-05	0.000854	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.02e-05	0.000851	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.02e-05	0.000851	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.01e-05	0.000838	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	9.89e-06	0.000822	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	9.83e-06	0.000818	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	9.58e-06	0.000796	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.52e-06	0.000792	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.33e-06	0.000776	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	9.25e-06	0.000769	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EIF2AK2—epilepsy syndrome	9.11e-06	0.000758	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AQP1—epilepsy syndrome	8.98e-06	0.000747	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.62e-06	0.000717	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPIA—epilepsy syndrome	8.43e-06	0.000701	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG2—epilepsy syndrome	8.34e-06	0.000693	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	8.21e-06	0.000683	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	8.12e-06	0.000676	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	8.12e-06	0.000675	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CHRM3—epilepsy syndrome	8.12e-06	0.000675	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	8.07e-06	0.000672	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.02e-06	0.000667	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.56e-06	0.000629	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.41e-06	0.000616	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.31e-06	0.000608	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	7.29e-06	0.000606	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	6.94e-06	0.000577	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BCHE—epilepsy syndrome	6.91e-06	0.000575	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG2—epilepsy syndrome	6.62e-06	0.000551	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	6.59e-06	0.000548	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLCB1—epilepsy syndrome	6.52e-06	0.000542	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TH—epilepsy syndrome	6.5e-06	0.00054	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	6.45e-06	0.000536	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	6.41e-06	0.000533	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.39e-06	0.000532	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.36e-06	0.000529	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A1—epilepsy syndrome	6.25e-06	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JUNB—epilepsy syndrome	6.2e-06	0.000516	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS1—epilepsy syndrome	6.16e-06	0.000512	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.11e-06	0.000508	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HBEGF—epilepsy syndrome	5.87e-06	0.000489	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.8e-06	0.000483	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	5.79e-06	0.000481	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT3—epilepsy syndrome	5.77e-06	0.00048	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADAM10—epilepsy syndrome	5.63e-06	0.000468	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	5.51e-06	0.000458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BCHE—epilepsy syndrome	5.48e-06	0.000456	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—epilepsy syndrome	5.42e-06	0.000451	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAT—epilepsy syndrome	5.35e-06	0.000445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDC42—epilepsy syndrome	5.26e-06	0.000438	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	5.23e-06	0.000435	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCB1—epilepsy syndrome	5.2e-06	0.000433	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLCB1—epilepsy syndrome	5.17e-06	0.00043	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TH—epilepsy syndrome	5.16e-06	0.000429	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX1—epilepsy syndrome	4.84e-06	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HES1—epilepsy syndrome	4.82e-06	0.000401	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FYN—epilepsy syndrome	4.68e-06	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—H2AFX—epilepsy syndrome	4.67e-06	0.000388	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—YWHAZ—epilepsy syndrome	4.5e-06	0.000374	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CCR5—epilepsy syndrome	4.33e-06	0.00036	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—epilepsy syndrome	4.3e-06	0.000358	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAT—epilepsy syndrome	4.25e-06	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AGT—epilepsy syndrome	4.24e-06	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—epilepsy syndrome	4.16e-06	0.000346	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCB1—epilepsy syndrome	4.13e-06	0.000344	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TSC2—epilepsy syndrome	4.03e-06	0.000335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—epilepsy syndrome	3.94e-06	0.000328	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX1—epilepsy syndrome	3.84e-06	0.000319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6ST—epilepsy syndrome	3.7e-06	0.000308	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—epilepsy syndrome	3.67e-06	0.000305	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—epilepsy syndrome	3.57e-06	0.000297	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AGT—epilepsy syndrome	3.37e-06	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—epilepsy syndrome	3.3e-06	0.000274	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—epilepsy syndrome	3.25e-06	0.000271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF2—epilepsy syndrome	2.99e-06	0.000249	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.85e-06	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—epilepsy syndrome	2.83e-06	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTOR—epilepsy syndrome	2.72e-06	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—epilepsy syndrome	2.58e-06	0.000215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SRC—epilepsy syndrome	2.18e-06	0.000182	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.43e-06	0.000119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—epilepsy syndrome	1.36e-06	0.000113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.14e-06	9.45e-05	CbGpPWpGaD
